News about Biotechnology, Pharmaceutical and Healthcare

09:36 EST 1st December 2015 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 13,000+

Tuesday 1st December 2015

We will not accept a doctor’s contract that is unsafe for patients

I was delighted to read your editorial ‘Pharmacists must support their junior doctor colleagues’ and would like to thank you for your support. This is a worrying time for the NHS, and the way we are going to protect the NHS we all love is to work together and support each other across disciplines, specialties and levels ...

Investment in pharma manufacturing 'key to driving UK economy'

Investing an additional £1.2 billion in UK manufacturing processes to increase robotics and automation could add as much as £60.5bn to the UK economy over the next decade. research suggests. The ‘Future-proofing UK manufacturing’ report, from Barclays Bank, indicates that investing in automation technology will help to increase the international competitiveness of the UK’s manufacturing se...

New web portal highlights UK strengths in medicines manufacturing

A new web portal has been launched to provide a platform to promote the UK’s strengths and capabilities in medicines manufacturing.  The portal is developed by the Knowledge Transfer Network (KTN), on behalf of the Medicines Manufacturing Industry Partnership (MMIP). Demand for the portal arose when research showed there is confusion about UK’s activity in this sector, in terms of the cur...

Collaboration between MPP and University of Liverpool targets HIV nanomedicines

The Medicines Patent Pool (MPP) and the University of Liverpool have agreed a partnership to use the university’s solid drug nanoparticles (SDN) technology to develop antiretrovirals as nanomedicines. The agreement covers 135 low- and middle-income countries and two high-income countries in Africa, where companies based anywhere in the world will have the right to make, use and distribute lower ...

EU approval for Gilead’s HIV combo Genvoya

Gilead Sciences has won marketing authorisation from the European Commission (EC) for the once-daily single tablet regimen Genvoya as a HIV-1 infection treatment. Genvoya (elvitegravir/cobicistat, emtricitabine and tenofovir alafenamide fumarate, or TAF) is now recommended in the European Union (EU) for the treatment of adults and adolescents (who are aged 12 years and older with body weight at le...

FDA approves BMS and AbbVie’s Empliciti for multiple myeloma

The US healthcare regulator has approved Empliciti – a multiple myeloma treatment co-developed by Bristol-Myers Squibb and AbbVie. The FDA signed-off on Empliciti (elotuzumab) as a treatment for multiple myeloma in combination with Celgene’s Revlimid (lenalidomide) and the chemotherapy treatment dexamethasone, in patients who have received one to three prior therapies. read more

Chromatography Resins Market 2015: Drug Discovery by Technique & Geography - Global Market Trends & Forecasts to 2020

Chromatography Resins Market in Drug Discovery by Technique (Ion Exchange, Affinity (Protein A, G & L), Hydrophobic Interaction, Size Exclusion, Multi Modal and Others) & Geography - Global Market Trends & Forecasts to 2020  The market for chromatography resins in drug discovery application is estimated at $238.07 Million in 2014 and is projected to grow at a CAGR of 7.0% between ...

DataApex and ACCHROM Instrument Technologies Co. Ltd. Announce OEM Cooperation

DataApex, a leader in chromatography software, and ACCHROM Instrument Technologies, a Chinese analytical instrument provider, announce the OEM cooperation. ACCHROM Technologies will market an OEM version of Clarity Chromatography Software under the name ACstation Chromatography Software.  ACstation includes control drivers for a complete S6000 HPLC system that cover pumps, auto sampler, colum...

Trajan Welcomes Australian Prime Minister to Showcase its ‘Disruptive Innovation’ with Academia and Start-Ups

Trajan spearheading Turnbull Government’s new innovation agenda Trajan Scientific and Medical has highlighted to Australia’s Prime Minister Malcolm Turnbull that “disruptive innovation” is well underway locally and globally, welcoming him to the company’s Global Headquarters in Melbourne, Australia, to showcase Trajan’s pioneering partnerships with academia and ...

Chromatrap ChIP-seq Protocol Yields Improved Results

Chromatrap®, a business unit of Porvair Sciences, has developed a new protocol that further extends the many advantages of its popular Chromatin Immunoprecipitation Sequencing (ChIP-seq) assay kits. Key developments for the Chromatrap® ChIP-seq kit (version 1.2) include high quality chromatin can now be achieved via sonication or enzymatic digestion ; high and low abundant enrichment is po...

World First Blood Cancer Drug Trial Reveals Life-Changing Results

Clinicians from the University of Leicester and Leicester’s Hospitals lead an international clinical trial for patients with blood cancer ‘This drug has changed patients’ lives; from desperate and tired they are now leading a normal and really active life. This is hugely rewarding and encouraging.’ Dr Harriet Walter, University of Leicester Researchers from the University o...

Monday 30th November 2015

University of Liverpool - SME Voucher Scheme

What is it? The Technology Directorate manages a suite of analytical facilities in the Life Science Faculty at the University of Liverpool. Expertly run and containing world class technology, they provide a valuable resource to address research probl...

What will Amazon’s drone delivery look like?

Dan BerthiaumeSee a video showing how Amazon’s delivery drones — which take off like a helicopter and then fly like a small airplane for up to 15 miles — will work.  read more

Seattle pharmacy shares preliminary One-Step PrEP pilot results

David SalazarThe pilot’s findings come at a time when the CDC noted that 1-in-3 primary care physicians and nurse practitioners do not know what PrEP is despite the promise it has shown to prevent HIV among high-risk groups.  read more

NYT highlights potential pitfalls of misusing OTC meds

The New York Times’ Well blog on Monday featured a post that provided an overview of the several ways that people might be misusing over-the-counter product despite their potential to help consumers — from improper label reading to unintentional dependence and the potential for medication to lose its effectiveness over time, leading to larger-than-recommended doses. (New York Times) re...

Pilot shows promise for pharmacist role in improving blood pressure outcomes

The six-month pilot program included 270 HealthPartners members who had a diagnosis of hypertension and a prescription for medication to lower blood pressure at a Sterling pharmacy.  read more

Haggen sells 47 locations, 30 back to Albertsons

Michael JohnsenAll 30 stores sold back to Albertsons were former Albertsons, Safeway or Vons stores that had been sold to Haggen earlier this year.  read more

Discount Drug opens two more MetroHealth clinics

Michael JohnsenThe two clinics are part of a plan to open five offices in locations within Cuyahoga County. read more

Walgreens, UN Foundation expand ‘Give a Shot’ offering for #GivingTuesday

Michael JohnsenFor every immunization, including flu shots, administered at a Walgreens pharmacy, the value of two life-saving vaccines will be donated to a child in a developing country. read more

Walgreens, UN Foundation expand 'Give a Shot' offering for #GivingTuesday

Michael JohnsenFor every immunization, including flu shots, administered at a Walgreens pharmacy, the value of two life-saving vaccines will be donated to a child in a developing country. read more

Diplomat to dispense Takeda’s Ninlaro

David SalazarTakeda’s Ninlaro is a treatment for patients with multiple myeloma who have had at least one prior therapy.  read more

More Americans planning for flu shot this year, survey finds

Michael JohnsenApproximately 35% received the flu shot at a doctor’s office, followed by 27% who received it at a pharmacy.  read more

Walmart customers take advantage of company's mobile/in-store integration

Michael JohnsenWalmart "opened the doors" to its Cyber Monday deals Sunday night at 8 p.m. read more

Diabetes treatment effective in liver disease

Almost two fifths of patients given liraglutide had resolution of the common liver disease called NASH.

Oramed inks China licensing deal for oral insulin candidate

Hefei will manufacture the API for Oramed's oral insulin tablet as part of a potential $50m licensing deal in China, Hong Kong and Macau.